ASKC200 for knee osteoarthritis pain
Part of Bones, joints & muscles, Pain clinical trials.
This trial tests a new drug called ASKC200 to see if it is safe and helps reduce knee pain caused by osteoarthritis. If you have had knee pain for at least 6 months and meet the other requirements, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 40 and 75 years old.
- You have had knee osteoarthritis pain for at least 6 months.
- Your knee X-ray shows a moderate level of arthritis (grade II or III).
- Your knee pain is at least a 5 on a 0-to-10 scale (with 10 being worst pain).
- You are willing to stop taking other pain medicines and use only the acetaminophen provided by the study.
- Your body mass index (BMI) is 40 or lower.
- You have not had knee surgery or injections in the study knee recently (within 3 to 6 months).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies ICM-203, a new treatment, to see if it is safe and if it can help symptoms in people with knee osteoarthritis. It mainly looks at safety and early signs of benefit for knee pain and function.
This study tests an experimental drug called LY4065967 to see if it can help reduce pain from osteoarthritis in the knee. You'll be in the trial for several months, with regular check-ins and pain assessments.
This trial tests if a new medicine, NNC0487-0111, can help people with excess weight and knee osteoarthritis lose weight and reduce knee pain. It is for people who have had knee pain for at least three months and who can stop taking pain relievers for short periods before study visits.
This study tests how well and how safely a knee treatment works for adults with painful knee osteoarthritis seen on X-ray. You might join if you need meaningful pain relief and help with daily function, and can complete required scans and study instructions.
This trial tests if a new medication called MAG200, injected into the knee, can reduce pain and improve function in people with moderate to severe knee osteoarthritis. You will receive either the study drug or a placebo (an inactive substance) to compare results.
This trial tests a study drug called SL1002 to see if it reduces knee pain from osteoarthritis. It may be an option for people with chronic knee pain who haven't found enough relief from current treatments.
Hear when a new Pain trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.